Medicine and Dentistry
Systematic Review
100%
Combination Therapy
58%
Randomized Controlled Trial
50%
Alcoholic Polyneuropathy
50%
Psychotomimetic
50%
Substance Use Disorder
50%
Patient Experience
50%
Substance Abuse
41%
Ketamine
33%
Psilocybine
33%
Tobacco Dependence
25%
Patient Care
25%
Mescaline
16%
Ibogaine
16%
Placebo
16%
Diseases
16%
Midomafetamine
16%
Lysergide
16%
Addictive Behavior
12%
Independent Reviewer
12%
Buprenorphine
12%
Maintenance Therapy
12%
Treatment Planning
12%
Social Interaction
12%
Design Evaluation
12%
Partial Agonist
12%
Adverse Event
8%
Arm
8%
Cannabis Use
8%
Observational Study
8%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
58%
Diseases
58%
Drug Dependence
50%
Randomized Controlled Trial
50%
Psychotomimetic
50%
Psilocybin
33%
Ketamine
33%
Tobacco Dependence
25%
Lysergide
16%
Ibogaine
16%
Placebo
16%
Mescaline
16%
MDMA
16%
Buprenorphine
16%
Partial Agonist
16%
Drug Craving
8%
Adverse Event
8%
Cannabis
8%
Observational Study
8%
Remission
8%
Neuroscience
Psychotomimetic
50%
Substance Abuse
50%
Ketamine
33%
Psilocybin
33%
Randomized Controlled Trial
33%
Tobacco Dependence
25%
Mescaline
16%
Ayahuasca
16%
Placebo
16%
Iboga
16%
Lysergic Acid Diethylamide
16%
MDMA
16%
Cannabis
8%
